On November tenth, Health and Human Services Secretary Robert F. Kennedy Junior announced a significant shift in womens health policy. The black box warning on estrogen-based HRT products, in place for over two decades, will be removed. This decision follows a re-evaluation of a study suggesting HRT might accelerate breast cancer, which was later found to be misrepresented. The change applies to both bio-identical and synthetic hormones, leaving the decision to individuals and their doctors. The move has been widely welcomed by womens health groups, restoring balance to womens health policy.

The Daily News Now! — Every city. Every story. AI-powered.

Hosted on Acast. See acast.com/privacy for more information.